The Anti-Osteoporotic Drug Preferences of Physiatrists: A Multicenter Descriptive Study
Aim: The purpose of this multicenter descriptive study is to determine the preferences of physiatrists in our country for anti-osteoporotic drugs in patients with primary and secondary osteoporosis. Materials and Methods: This study was carried out in 10 provinces of Turkey. The diagnosis of osteo...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Galenos Yayinevi
2012-08-01
|
| Series: | Türk Osteoporoz Dergisi |
| Subjects: | |
| Online Access: | http://www.turkosteoporozdergisi.org/article_4300/The-Anti-osteoporotic-Drug-Preferences-Of-Physiatrists-A-Multicenter-Descriptive-Study |
| _version_ | 1828019490292498432 |
|---|---|
| author | Yeşim Gökçe Kutsal Oya Özdemir Sevilay Karahan |
| author_facet | Yeşim Gökçe Kutsal Oya Özdemir Sevilay Karahan |
| author_sort | Yeşim Gökçe Kutsal |
| collection | DOAJ |
| description | Aim: The purpose of this multicenter descriptive study is to determine the preferences of physiatrists in our country for anti-osteoporotic drugs
in patients with primary and secondary osteoporosis.
Materials and Methods: This study was carried out in 10 provinces of Turkey. The diagnosis of osteoporosis was based on World Health
Organization criteria using dual-energy x-ray absorptiometry. Patients with a spine and/or hip T-score ≤-2.5 were considered as osteoporotic. 714
patients over 18 years old with primary or secondary osteoporosis were included in the study. In addition to socio-demographic characteristics
and chronic use of medications and/or additional systemic diseases that cause secondary osteoporosis were questioned and antiosteoporotic
drugs that are recommended by their physicians were recorded.Results: The physicians’ preferred vitamin D and calcium as the prior treatment both in primary and secondary osteoporosis. The most commonly
used anti-osteoporotic agent was alendronate from the biphosphonate group. It was followed by ibandronate, risedronate, strontium ranelate,
calcitonin, zoledronate, raloxifene, parathyroid hormone (PTH) and hormone replacement therapy (HRT) in the primary osteoporosis and
risedronate, ibandronate, calcitonin, strontium ranelate, zoledronate, PTH, HRT and raloxifene in the secondary osteoporosis, respectively.
Conclusion: The physician should choose the most suitable treatment for the patient based on fracture risk, medical history, previous
treatments for osteoporosis, concomitant diseases, treatment-induced risks and benefits, and the relation between financial cost and potential
benefit. (Turkish Journal of Osteoporosis 2012;18: 42-6) |
| first_indexed | 2024-04-10T11:20:59Z |
| format | Article |
| id | doaj.art-3e4412b5a8a841b59dd3c524680797b6 |
| institution | Directory Open Access Journal |
| issn | 2147-2653 |
| language | English |
| last_indexed | 2024-04-10T11:20:59Z |
| publishDate | 2012-08-01 |
| publisher | Galenos Yayinevi |
| record_format | Article |
| series | Türk Osteoporoz Dergisi |
| spelling | doaj.art-3e4412b5a8a841b59dd3c524680797b62023-02-15T16:18:38ZengGalenos YayineviTürk Osteoporoz Dergisi2147-26532012-08-01182424610.4274/tod.63634The Anti-Osteoporotic Drug Preferences of Physiatrists: A Multicenter Descriptive StudyYeşim Gökçe Kutsal0Oya Özdemir1Sevilay Karahan2Hacettepe Üniversitesi Tıp Fakültesi, Fiziksel Tıp ve Rehabilitasyon Anabilim Dalı, Ankara, TürkiyeHacettepe Üniversitesi Kastamonu Tıp Fakültesi, Fiziksel Tıp ve Rehabilitasyon Anabilim Dalı, Ankara, Türkiye Hacettepe Üniversitesi Tıp Fakültesi, Biyoistatistik Anabilim Dalı, Ankara, TürkiyeAim: The purpose of this multicenter descriptive study is to determine the preferences of physiatrists in our country for anti-osteoporotic drugs in patients with primary and secondary osteoporosis. Materials and Methods: This study was carried out in 10 provinces of Turkey. The diagnosis of osteoporosis was based on World Health Organization criteria using dual-energy x-ray absorptiometry. Patients with a spine and/or hip T-score ≤-2.5 were considered as osteoporotic. 714 patients over 18 years old with primary or secondary osteoporosis were included in the study. In addition to socio-demographic characteristics and chronic use of medications and/or additional systemic diseases that cause secondary osteoporosis were questioned and antiosteoporotic drugs that are recommended by their physicians were recorded.Results: The physicians’ preferred vitamin D and calcium as the prior treatment both in primary and secondary osteoporosis. The most commonly used anti-osteoporotic agent was alendronate from the biphosphonate group. It was followed by ibandronate, risedronate, strontium ranelate, calcitonin, zoledronate, raloxifene, parathyroid hormone (PTH) and hormone replacement therapy (HRT) in the primary osteoporosis and risedronate, ibandronate, calcitonin, strontium ranelate, zoledronate, PTH, HRT and raloxifene in the secondary osteoporosis, respectively. Conclusion: The physician should choose the most suitable treatment for the patient based on fracture risk, medical history, previous treatments for osteoporosis, concomitant diseases, treatment-induced risks and benefits, and the relation between financial cost and potential benefit. (Turkish Journal of Osteoporosis 2012;18: 42-6)http://www.turkosteoporozdergisi.org/article_4300/The-Anti-osteoporotic-Drug-Preferences-Of-Physiatrists-A-Multicenter-Descriptive-StudyOsteoporosismedicinetreatment |
| spellingShingle | Yeşim Gökçe Kutsal Oya Özdemir Sevilay Karahan The Anti-Osteoporotic Drug Preferences of Physiatrists: A Multicenter Descriptive Study Türk Osteoporoz Dergisi Osteoporosis medicine treatment |
| title | The Anti-Osteoporotic Drug Preferences of Physiatrists: A Multicenter Descriptive Study |
| title_full | The Anti-Osteoporotic Drug Preferences of Physiatrists: A Multicenter Descriptive Study |
| title_fullStr | The Anti-Osteoporotic Drug Preferences of Physiatrists: A Multicenter Descriptive Study |
| title_full_unstemmed | The Anti-Osteoporotic Drug Preferences of Physiatrists: A Multicenter Descriptive Study |
| title_short | The Anti-Osteoporotic Drug Preferences of Physiatrists: A Multicenter Descriptive Study |
| title_sort | anti osteoporotic drug preferences of physiatrists a multicenter descriptive study |
| topic | Osteoporosis medicine treatment |
| url | http://www.turkosteoporozdergisi.org/article_4300/The-Anti-osteoporotic-Drug-Preferences-Of-Physiatrists-A-Multicenter-Descriptive-Study |
| work_keys_str_mv | AT yesimgokcekutsal theantiosteoporoticdrugpreferencesofphysiatristsamulticenterdescriptivestudy AT oyaozdemir theantiosteoporoticdrugpreferencesofphysiatristsamulticenterdescriptivestudy AT sevilaykarahan theantiosteoporoticdrugpreferencesofphysiatristsamulticenterdescriptivestudy AT yesimgokcekutsal antiosteoporoticdrugpreferencesofphysiatristsamulticenterdescriptivestudy AT oyaozdemir antiosteoporoticdrugpreferencesofphysiatristsamulticenterdescriptivestudy AT sevilaykarahan antiosteoporoticdrugpreferencesofphysiatristsamulticenterdescriptivestudy |